Toward Health Equity Oncology Grant®
This grant supports projects that advance health equity in cancer care by addressing disparities and improving access for underserved populations in the US, Australia, Canada, and Europe.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (Application deadline, projected)
Funding Amounts: Amounts not specified; refer to program page for details.
Summary: Supports projects advancing health equity in cancer care by addressing disparities and improving access for underserved communities in the US, Australia, Canada, and Europe.
Key Information: This is a forecasted opportunity; dates and details are subject to change.
Description
The Toward Health Equity Oncology Grant® is an initiative by Gilead Sciences designed to support organizations and projects that advance health equity for individuals impacted by cancer. The grant focuses on addressing disparities in cancer care and outcomes, improving access to cancer screening, diagnosis, treatment, and survivorship support—particularly among underserved communities—and fostering models, policies, or interventions that promote equity in oncology. The geographic scope includes the United States, Australia, Canada, and Europe.
